about   CII home   shop   checkout

Japan-Flag  Korea-Flag  China-Simplified-Flag  China-Traditional-Flag 

Conference Menu

Current Event

Day 1
Day 2
Day 3
Delegate List
Welcome Letter
PDF Download
Hotel & Travel
Sponsor & Exhibit
Exhibit Floorplan
Resource Center
Press Pass
Request Brochure 

Co-Located with:

Next-Gen Kinase Inhibitors 

Corporate Sponsors:

Chemical Computing GroupNEW logo 





Sponsoring Society:


Media Sponsor:

Bio-IT World 

Media Partners:


chemical biology 




FierceHealth IT 




Insight Pharma Reports 


Pharm Cast 



Science AAAS 

Technology Networks.com 

The Scientist 

Select Science 

Bio-IT World News Bulletins 

ARC Bioinformatics Partnering 

CHI's 13th Annual Structure-Based Drug Design Conference - Overview

Conference Proceeding CD Now Available
  • Speaker Presentations
  • Poster Abstracts
  • and More!

2013 Archived Content

At CHI/Bio-IT World's thirteenth annual Structure-Based Drug Design conference, you will hear
about developments in insilico technology, as well as experimental approaches useful for accurately
predicting and modeling the structures of proteins in structure-based drug design efforts. In addition,
examples of successful applications of such technology approaches to genome-to-drug lead
investigations will be addressed.

Advisory Board

Dr. Don Jacobs, University of North Carolina Charlotte

Dr. Jon Mason, Heptares Therapeutics Ltd.

Dr. Stephan Schurer, University of Miami

Dr. Xiayang Qiu, Pfizer, Inc.

Dr. David Dalgarno, ARIAD Pharmaceuticals, Inc.

Dr. Gergely Toth, University of Cambridge

Dr. Scot Mente, Pfizer Global R&D Groton Labs

Final Agenda 

Keynote Presentation

Tomi Sawyer-2013Drugging the Undruggable:
Transforming Nature's α-Helix into Breakthrough Medicines

Tomi Sawyer, Ph.D., CSO, Aileron Therapeutics


Reasons to Attend:

  • HEAR about novel ligand-centric approach for force field calculation.
  • BE inspired to set up ambitious projects on SBDD using automated analytics pipeline and long-timescale explicit molecular simulation.
  • EXAMINE the role of water/solvent in structure-based drug design.
  • RE-DISCOVER the potential of fragment-based drug design through simulation of the complete binding process.
  • EXPLORE the epigenomic protein landscapes of cancer cells for drug design.
  • MEET potential collaborators from both academic and industry practitioners.


  • Structure-Based Drug Design for Kinase
  • Drug Resistance
  • Force Field Calculation
  • GPCR
  • Water & Solvation in Drug Design
  • Fragment-Based Drug Design
  • Protein-Protein Interaction
  • Epigenetic Targeting

MORNING SHORT COURSE (JUNE 19, 9:00 AM - 12:00 PM)*  

Structure-Based Drug Design for Epigenetic Targets

Johnathan R. Whetstine, Ph.D., Assistant Professor of Medicine, Harvard Medical School
Philip Fallon, Ph.D., Senior Medicinal Chemist, Domainex Ltd.

Click here to view details.

DINNER SHORT COURSE (JUNE 19, 6:00-8:00 PM)*  

Chemical Computing Group-DO NOT USEA Uniform Framework for Computer-Aided Biologics Design


Chris Williams, Ph.D., Principal Scientist, Chemical Computing Group

Click here to view details.

*Separate registration required.

Bio-IT World Product Directory